Verification of B-lymphocyte activating factor’s involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease

BACKGROUND: Ten to forty percent of nonalcoholic steatohepatitis (NASH) and HCV-related chronic liver disease (CLD-C) patients have antinuclear antibodies (ANAs). However, the relationship between autoimmune response and insulin resistance remains uncertain among those patients. The primary purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Himoto, Takashi, Fujita, Koji, Nomura, Takako, Tani, Joji, Morishita, Asahiro, Yoneyama, Hirohito, Haba, Reiji, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470186/
https://www.ncbi.nlm.nih.gov/pubmed/28630652
http://dx.doi.org/10.1186/s13098-017-0243-z

Ejemplares similares

Ejemplares similares